Related Experiment Video
Updated: Sep 23, 2025

A Visual Description of the Dissection of the Cerebral Surface Vasculature and Associated Meninges and the Choroid Plexus from Rat Brain
Published on: November 14, 2012
Geometric and Morphologic Features of Ruptured Intracranial Aneurysms Associated with Methamphetamine Use
M Travis Caton1, Jeffrey Vitt2, Eric R Smith1
1Department of Radiology and Biomedical Imaging, Neurointerventional Section, University of California, San Francisco, California, USA.
Background:
Methamphetamine (MA) use is associated with poor outcomes after aneurysmal subarachnoid hemorrhage (aSAH). MA exerts both hemodynamic and inflammatory effects, but whether these manifest with altered intracranial aneurysm (IA) remodeling is unknown. The objective of this study was to compare IA geometric and morphologic features in patients with and without MA detected on urine toxicology (Utox) at presentation.
Methods:
We retrospectively reviewed 160 consecutive patients with SAH and Utox at time of admission. Geometric-morphologic IA characteristics were assessed by blinded neuroradiologists. Studied features were maximum sac diameter, location, size, ellipsoid volume, aspect ratio, size ratio, volume: neck ratio, dome: neck ratio, bottleneck factor, morphology (saccular, fusiform/dissecting, blister, mycotic), and presence of bleb, vasculopathy, or additional unruptured IA.
Results:
Of 139/160 patients with aSAH, 23/139 (16.5%) were Utox MA+. There was no difference in aneurysm subtype frequency, presence of bleb, vasculopathy, or presence of an additional (unruptured) aneurysm with a trend toward posterior circulation location and higher Hunt and Hess grade (P = 0.09 for both) in the MA+ group. Maximum IA sac diameter, ellipsoid volume, dome-neck ratio, and size ratio were similar between groups. Only the aspect ratio (AR) differed between groups (MA+ = 2.20 vs. MA- = 1.74, P = 0.02). The AR remained a significant predictor of Utox MA+ in a multiple logistic regression analysis (odds ratio 1.87, 95% confidence interval 1.06-3.39).
Conclusions:
Active use of methamphetamine is independently associated with larger AR in patients with ruptured IA. This may indicate hazardous remodeling due to hemodynamic and/or inflammatory changes.
Insights
Methamphetamine use in patients with ruptured intracranial aneurysms is linked to a higher aspect ratio, suggesting hazardous remodeling. This finding highlights potential risks associated with methamphetamine in subarachnoid hemorrhage patients.
Area of Science:
- Neurosurgery
- Radiology
- Toxicology
Background:
- Methamphetamine (MA) use is linked to poor outcomes after aneurysmal subarachnoid hemorrhage (aSAH).
- The effects of MA on intracranial aneurysm (IA) remodeling are not well understood.
- This study investigates IA geometric and morphologic features in MA users versus non-users.
Purpose of the Study:
- To compare IA geometric and morphologic features in patients with and without methamphetamine (MA) detected via urine toxicology (Utox).
- To determine if MA use is associated with specific IA remodeling patterns.
Main Methods:
- Retrospective review of 160 patients with SAH and Utox at admission.
- Blinded neuroradiologists assessed IA characteristics including diameter, volume, ratios, and morphology.
- Statistical analysis compared features between MA-positive and MA-negative groups.
Main Results:
- 16.5% of patients were Utox MA+; no differences in aneurysm subtype, blebs, vasculopathy, or additional aneurysms.
- Maximum IA sac diameter, ellipsoid volume, dome-neck ratio, and size ratio were similar between groups.
- A significantly higher aspect ratio (AR) was observed in the MA+ group (2.20 vs. 1.74, P=0.02), and AR predicted MA+ status.
Conclusions:
- Active methamphetamine use is independently associated with a larger aspect ratio in ruptured intracranial aneurysms.
- This altered AR may indicate hazardous IA remodeling due to hemodynamic and/or inflammatory changes.
- Further research is needed to elucidate the mechanisms behind MA-associated IA remodeling.
Related Concept Videos
Aneurysm I: Introduction
Aneurysm II: Clinical Manifestations and Diagnostic Studies
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

